Search results
SMART Inhalers: The Overlooked Solution in Asthma Management
SciTechDaily· 6 days agoAccording to research presented at the ATS 2024 International Conference, only 14.5 percent of adult...
GSK's experimental drug shows promise in reducing severe asthma attacks
Reuters via Yahoo News· 7 days agoThe drug, called depemokimab, showed "significant and meaningful reductions" in asthma attacks for...
GSK Studies on Depemokimab for Severe Asthma Meet Primary Goals
Zacks· 6 days agoGSK's depemokimab has the potential to become the first ultra-long-acting biologic for severe asthma with a six-month dosing schedule
GSK's experimental drug shows promise in reducing severe asthma attacks
Reuters· 7 days ago, opens new tab experimental drug met its primary goal of reducing asthma attacks in a late-stage...
Sanofi reports positive data from Phase II asthma treatment trial
Clinical Trials Arena via Yahoo Finance· 4 days agoSanofi has announced positive outcomes from a Phase II clinical trial of rilzabrutinib, an oral...
Kids with asthma more likely to need hospital care during heat waves
United Press International via Yahoo News· 6 days ago"We continue to see global temperatures rise due to human-generated climate change, and we can...
GSK Experimental Drug Reduces Severe Asthma Attacks in Key Trial
Bloomberg· 7 days agoAn experimental drug from GSK Plc reduced asthma attacks in late-stage trials, paving the way for a...
GSK says its experimental drug reduced asthma attacks with only two doses a year
Quartz· 6 days agoPeople suffering from a severe form of asthma could soon see their symptoms improve with a new...
Too Few Asthma Patients Are Using Updated Inhalers
WFMZ Eastern Pennsylvania and Western New Jersey· 5 days agoImproved inhalers are now available to help control asthma and treat sudden attacks, but a new study shows that hardly anyone’s using them. The new...
BTK Inhibitor Likely to Get a Pass to Phase III in Uncontrolled Asthma
MedPage Today· 4 days agoTreatment with an investigational oral Bruton's tyrosine kinase (BTK) inhibitor was associated with...
